News Center
Statement regarding criminals impersonating our company to engage in fraudulent activities.
Release time:
2023-05-08
Livzon Pharmaceutical Group Inc. (hereinafter referred to as "the Company") has noticed that recently some illegal individuals have impersonated the Company, using WeChat,APPand other platforms to publish false information, and have committed fraud and illegal fundraising activities under the guise of investing in the Company's pharmaceutical projects. In order to protect the rights and interests of the vast number of users and the Company's legitimate interests, we hereby make the following solemn statement:
1. The Company has not launched an officialAPP,has nevercarried outfinancial management business related to the Company's pharmaceuticals,and has never authorized any individual or organization to carry out such business..The information related to the Company's pharmaceuticals and its subsidiaries shall be subject to the announcement documents on the Company's website, and we kindly ask thevast number of usersto pay attention and carefully discern, and not to easily trust any information from other unofficial channels, to avoid being deceived.2. The Company'sofficial website ishttps://www.livzon.com.cnThe information related to the Company's pharmaceuticals and its subsidiaries shall be subject to the announcement documents on the Company's website, and we kindly ask the
, the national unified customer service email address isxlz@livzon.com.cnThe Exchange Telnumber is:0756-8135888,, and the official WeChat subscription account is "},{号码为：0756-8135888，官方微信订阅号为“丽珠医药”。
三、本公司郑重提醒广大用户：请务必提高警惕，切勿轻易透露个人信用信息或盲目支付任何可疑费用， 保护自身合法权益和自身财产安全。如您发现存在上述假冒情况的任何企业、网站或个人，或接到此类电子邮件、信息或电话等异常情况，请直接拨打本公司集团总机号码进行核实、举报或向监管部门反映；若有资金损失，请向当地公安机关报案。
四、本公司已向公安机关报案，任何不法行为及犯罪分子必将绳之以法。
特此声明The information related to the Company's pharmaceuticals and its subsidiaries shall be subject to the announcement documents on the Company's website, and we kindly ask the
丽珠医药集团股份有限公司
2023年5月6日
Related Information